Vivo Capital, LLC — 13F Holdings

2026 Q3  ·  55 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Vivo Capital, LLC maintained a portfolio of 55 distinct positions. The most significant new addition was Entera Bio Ltd, now representing 3.92% of the total fund value. They heavily accumulated shares in Faeth Therapeutics Inc, increasing the position by 17.0%. Conversely, Vivo Capital, LLC completely exited their position in Sinovac Biotech Ltd..
Position History hover any row below to update
Loading…
Vivo Capital, LLC Palo Alto, CA Venture Capital / Healthcare Investment AUM $909M
PCA Score Concentration Risk
Risk ENB
Total Positions
55
Quarter
2026 Q3
Top Holding
PRAX (8.7%)
Top 10 Concentration
51.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 55

Vivo Capital, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
PRAX
Praxis Precisio...
Healthcare 8.69% 8.29% #1 1
Prev: #2
6.5
—
no change no change
P
S
271,116 $78,957,113
$148.26 +109.7%
$291.23 +6.8%
2025 Q2 13F Filing 2026-09-30 2026-11-13
TRVI
Trevi Therapeut...
Healthcare 6.67% 8.68% #2 1
Prev: #1
4.7
—
-864,985 -17.0%
P
S
4,229,683 $60,569,061 2024 Q3 13F Filing 2026-09-30 2026-11-13
ERAS
Erasca Inc
Healthcare 6.49% 6.90% #3
Prev: #3
4.1
—
-106,793 -2.6%
P
S
4,020,619 $58,942,275 2024 Q2 13F Filing 2026-09-30 2026-11-13
AVBP
Arrivent BioPha...
Healthcare 5.95% 5.34% #4
Prev: #4
4.9
—
105,007 6.2%
P
S
1,787,104 $54,113,509 2026 Q1 13F Filing 2026-09-30 2026-11-13
ABVX
Abivax SA
Healthcare 4.52% 5.05% #5
Prev: #5
3.3
—
no change no change
P
S
414,899 $41,083,299 2025 Q3 13F Filing 2026-09-30 2026-11-13
ENTX
Entera Bio Ltd
Healthcare 3.92% — #6
Prev: #—
5.1
—
12,254,901 —
NEW
12,254,901 $35,661,762 2026 Q3 13F Filing 2026-09-30 2026-11-13
ACRS
Aclaris Therape...
Healthcare 3.88% 3.23% #7 4
Prev: #11
2.6
—
no change no change
P
S
6,694,637 $35,213,791 2016 Q1 13F Filing 2026-09-30 2026-11-13
ANRO
Alto Neuroscien...
Healthcare 3.82% 2.91% #8 6
Prev: #14
3.5
—
151,057 12.5%
P
S
1,359,915 $34,718,630 2025 Q4 13F Filing 2026-09-30 2026-11-13
TNGX
Tango Therapeut...
Healthcare 3.79% 3.94% #9 3
Prev: #6
2.5
—
no change no change
P
S
1,379,769 $34,425,237 2025 Q2 13F Filing 2026-09-30 2026-11-13
CRVS
Corvus Pharmace...
Healthcare 3.56% 3.83% #10 3
Prev: #7
2.4
—
no change no change
P
S
2,805,816 $32,323,000 2024 Q3 13F Filing 2026-09-30 2026-11-13
LBRX
LB Pharmaceutic...
Healthcare 3.38% 2.37% #11 7
Prev: #18
2.4
—
no change no change
P
S
800,000 $30,704,000 2025 Q3 13F Filing 2026-09-30 2026-11-13
KRSA
Korsana Bioscie...
Healthcare 3.09% — #12
Prev: #—
4.7
—
877,020 —
NEW
877,020 $28,064,640 2026 Q3 13F Filing 2026-09-30 2026-11-13
BLSM
Blossomhill The...
Healthcare 3.06% — #13
Prev: #—
4.7
—
1,493,740 —
NEW
1,493,740 $27,843,314 2026 Q3 13F Filing 2026-09-30 2026-11-13
SNSE
Faeth Therapeut...
Healthcare 2.76% 1.65% #14 9
Prev: #23
3.1
—
122,556 17.0%
P
S
844,576 $25,117,690 2026 Q1 13F Filing 2026-09-30 2026-11-13
CAMP
CAMP4 Therapeut...
Healthcare 2.48% 1.69% #15 7
Prev: #22
3.5
—
1,337,543 31.5%
P
S
5,584,111 $22,559,808 2025 Q3 13F Filing 2026-09-30 2026-11-13
ACHV
Achieve Life Sc...
Healthcare 2.45% 1.64% #16 8
Prev: #24
2.0
—
no change no change
P
S
2,751,032 $22,255,849 2026 Q2 13F Filing 2026-09-30 2026-11-13
SABS
SAB Biotherapeu...
Healthcare 2.41% 2.60% #17 1
Prev: #16
1.5
—
-384,898 -5.3%
P
S
6,915,011 $21,920,585 2025 Q3 13F Filing 2026-09-30 2026-11-13
DBVT
DBV Technologie...
Healthcare 2.39% 2.76% #18 3
Prev: #15
2.0
—
no change no change
P
S
1,844,758 $21,694,354 2024 Q4 13F Filing 2026-09-30 2026-11-13
DRUG
Bright Minds Bi...
Healthcare 2.29% 3.57% #19 11
Prev: #8
0.9
—
-139,293 -25.0%
P
S
417,879 $20,818,732 2024 Q4 13F Filing 2026-09-30 2026-11-13
DSGN
Design Therapeu...
Healthcare 2.23% 2.13% #20
Prev: #20
1.9
—
no change no change
P
S
1,612,903 $20,274,191 2021 Q1 13F Filing 2026-09-30 2026-11-13
ANTX
AN2 Therapeutic...
Healthcare 1.85% 1.39% #21 5
Prev: #26
1.7
—
no change no change
P
S
3,153,640 $16,777,365 2026 Q1 13F Filing 2026-09-30 2026-11-13
MLTX
Moonlake Immuno...
Healthcare 1.80% 2.49% #22 5
Prev: #17
1.7
—
no change no change
P
S
1,400,000 $16,380,000 2025 Q4 13F Filing 2026-09-30 2026-11-13
NERV
Minerva Neurosc...
Healthcare 1.59% 2.19% #23 4
Prev: #19
1.6
—
no change no change
P
S
4,322,747 $14,481,202 2016 Q2 13F Filing 2026-09-30 2026-11-13
ODTX
Odyssey Therape...
Healthcare 1.41% 0.98% #24 5
Prev: #29
1.6
—
no change no change
P
S
575,000 $12,776,500 2026 Q2 13F Filing 2026-09-30 2026-11-13
ORIC
Oric Pharmaceut...
Healthcare 1.37% 1.83% #25 4
Prev: #21
0.5
—
-924,394 -50.0%
P
S
924,392 $12,451,560 2023 Q3 13F Filing 2026-09-30 2026-11-13
EPRX
Eupraxia Pharma...
Healthcare 1.35% 0.81% #26 4
Prev: #30
1.5
—
no change no change
P
S
1,350,000 $12,285,000 2025 Q3 13F Filing 2026-09-30 2026-11-13
VOR
Vor Biopharma I...
Healthcare 1.16% — #27
Prev: #—
4.0
—
550,358 —
NEW
550,358 $10,500,831 2026 Q3 13F Filing 2026-09-30 2026-11-13
EDIT
Editas Medicine...
Healthcare 1.01% 1.05% #28 1
Prev: #27
1.4
—
no change no change
P
S
3,555,250 $9,136,993 2026 Q2 13F Filing 2026-09-30 2026-11-13
SRZN
Surrozen Inc
Healthcare 0.92% 0.62% #29 6
Prev: #35
1.4
—
no change no change
P
S
260,000 $8,366,800 2025 Q1 13F Filing 2026-09-30 2026-11-13
DYN
Dyne Therapeuti...
Healthcare 0.91% 3.16% #30 18
Prev: #12
0.4
—
-1,043,064 -67.0%
P
S
514,402 $8,287,016 2020 Q3 13F Filing 2026-09-30 2026-11-13
AURA
Aura Bioscience...
Healthcare 0.81% 0.76% #31 3
Prev: #34
1.3
—
no change no change
P
S
1,166,667 $7,326,669 2026 Q2 13F Filing 2026-09-30 2026-11-13
CUE
Cue Biopharma I...
Healthcare 0.80% — #32
Prev: #—
3.8
—
280,057 —
NEW
280,057 $7,245,075 2026 Q3 13F Filing 2026-09-30 2026-11-13
MNPR
Monopar Therape...
Healthcare 0.79% 0.77% #33
Prev: #33
1.3
—
no change no change
P
S
90,500 $7,210,135 2025 Q3 13F Filing 2026-09-30 2026-11-13
MSLE
Satellos Biosci...
Healthcare 0.76% 0.58% #34 3
Prev: #37
1.3
—
no change no change
P
S
813,666 $6,916,161 2026 Q2 13F Filing 2026-09-30 2026-11-13
OLMA
Olema Pharmaceu...
Healthcare 0.64% 0.77% #35 3
Prev: #32
1.3
—
no change no change
P
S
671,843 $5,804,724 2020 Q4 13F Filing 2026-09-30 2026-11-13
PEPG
Pepgen Inc
Healthcare 0.62% 0.38% #36 3
Prev: #39
1.2
—
no change no change
P
S
2,325,000 $5,626,500 2025 Q3 13F Filing 2026-09-30 2026-11-13
OKUR
Onkure Therapeu...
Healthcare 0.58% 0.80% #37 6
Prev: #31
1.2
—
no change no change
P
S
1,927,710 $5,253,010 2026 Q1 13F Filing 2026-09-30 2026-11-13
N/A
Attovia Therape...
Unknown 0.57% — #38
Prev: #—
3.7
—
300,000 —
NEW
300,000 $5,142,000 — 13F Filing 2026-09-30 2026-11-13
ADRX
ADARx Pharmaceu...
Healthcare 0.56% — #39
Prev: #—
3.7
—
255,158 —
NEW
255,158 $5,087,851 2026 Q3 13F Filing 2026-09-30 2026-11-13
TENX
Tenax Therapeut...
Healthcare 0.52% 3.32% #40 30
Prev: #10
1.2
—
no change no change
P
S
2,500,000 $4,725,000 2024 Q3 13F Filing 2026-09-30 2026-11-13
VALN
Valneva SE
Healthcare 0.52% 0.36% #41 1
Prev: #40
1.2
—
no change no change
P
S
763,199 $4,720,386 2021 Q2 13F Filing 2026-09-30 2026-11-13
AVTX
Avalo Therapeut...
Healthcare 0.46% 0.46% #42 4
Prev: #38
1.2
—
no change no change
P
S
275,000 $4,215,750 2026 Q2 13F Filing 2026-09-30 2026-11-13
CMPX
Compass Therape...
Healthcare 0.39% 1.55% #43 18
Prev: #25
0.2
—
-4,333,513 -55.9%
P
S
3,423,547 $3,560,489 2021 Q4 13F Filing 2026-09-30 2026-11-13
SERA
Sera Prognostic...
Healthcare 0.38% 0.27% #44 3
Prev: #41
1.2
—
no change no change
P
S
1,650,440 $3,449,420 2021 Q3 13F Filing 2026-09-30 2026-11-13
TIL
Instil Bio Inc
Healthcare 0.23% 0.21% #45 2
Prev: #43
1.1
—
no change no change
P
S
292,743 $2,119,459 2023 Q4 13F Filing 2026-09-30 2026-11-13
INM
InMed Pharmaceu...
Healthcare 0.12% 0.11% #46 2
Prev: #44
0.5
—
26,497 3.3%
P
S
824,874 $1,121,829 2026 Q2 13F Filing 2026-09-30 2026-11-13
BOLT
Bolt Biotherape...
Healthcare 0.03% 0.03% #47 2
Prev: #45
1.0
—
no change no change
P
S
72,414 $266,484 2021 Q1 13F Filing 2026-09-30 2026-11-13
KTTA
Pasithea Therap...
Healthcare 0.02% 0.02% #48 2
Prev: #46
0.5
—
-92,675 -19.9%
P
S
372,796 $183,788 2025 Q4 13F Filing 2026-09-30 2026-11-13
DTIL
Precision Biosc...
Healthcare 0.00% 0.00% #49 2
Prev: #47
1.0
—
no change no change
P
S
4,675 $29,266 2024 Q1 13F Filing 2026-09-30 2026-11-13
JSPR
Jasper Therapeu...
Healthcare 0.00% — #50
Prev: #—
3.5
—
5,364 —
NEW
5,364 $3,693 2026 Q3 13F Filing 2026-09-30 2026-11-13
Showing 1-50 of 55 holdings

Unlock Full Vivo Capital, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →